The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study

被引：0

作者：

Akito Nozaki

Masanori Atsukawa

Chisa Kondo

Hidenori Toyoda

Makoto Chuma

Makoto Nakamuta

Haruki Uojima

Koichi Takaguchi

Hiroki Ikeda

Tsunamasa Watanabe

Shintaro Ogawa

Norio Itokawa

Taeang Arai

Atsushi Hiraoka

Toru Asano

Shinichi Fujioka

Tadashi Ikegami

Toshihide Shima

Chikara Ogawa

Takehiro Akahane

Noritomo Shimada

Shinya Fukunishi

Hiroshi Abe

Akihito Tsubota

Takuya Genda

Hironao Okubo

Shigeru Mikami

Asahiro Morishita

Akio Moriya

Joji Tani

Yoshihiko Tachi

Naoki Hotta

Toru Ishikawa

Takeshi Okanoue

Yasuhito Tanaka

Takashi Kumada

Katsuhiko Iwakiri

Shin Maeda

机构：

[1] Yokohama City University Medical Center,Gastroenterological Center

[2] Nippon Medical School,Department of Internal Medicine, Division of Gastroenterology and Hepatology

[3] Ogaki Municipal Hospital,Department of Gastroenterology

[4] National Hospital Organization Kyushu Medical Center,Department of Gastroenterology, Internal Medicine

[5] Kitasato University School of Medicine,Department of Hepatology

[6] Kagawa Prefectural Central Hospital,Department of Internal Medicine

[7] St. Marianna University School of Medicine,Department of Virology and Liver Unit

[8] Nagoya City University,Division of Gastroenterology, Department of Internal Medicine

[9] Graduate School of Medical Sciences,Division of Gastroenterology, Department of Internal Medicine

[10] Nippon Medical School Chiba Hokusoh Hospital,Gastroenterology Center

[11] Nippon Medical School Musashikosugi Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[12] Ehime Prefectural Central Hospital,Department of Gastroenterology

[13] Tokyo Metropolitan Bokutoh Hospital,Department of Gastroenterology and Hepatology

[14] Okayama Saiseikai General Hospital,Department of Gastroenterology and Hepatology

[15] Tokyo Medical University Ibaraki Medical Center,Department of Gastroenterology

[16] Saiseikai Suita Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[17] Takamatsu Red Cross Hospital,Second Department of Internal Medicine

[18] Japanese Red Cross Ishinomaki Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[19] Otakanomori Hospital,Core Research Facilities for Basic Science

[20] Osaka Medical College,Department of Gastroenterology

[21] Shinmatsudo Central General Hospital,Department of Gastroenterology

[22] The Jikei University School of Medicine,Division of Gastroenterology, Department of Internal Medicine

[23] Juntendo Shizuoka University Hospital,Department of Gastroenterology

[24] Juntendo Nerima University Hospital,Department of Gastroenterology

[25] Kikkoman General Hospital,Department of Internal Medicine

[26] Kagawa University Graduate School of Medicine,Division of Hepatology, Department of Internal Medicine

[27] Mitoyo General Hospital,Department of Hepatology

[28] Yashima General Hospital,Department of Gastroenterology

[29] Bantane Hospital,undefined

[30] Fujita Health University School of Medicine,undefined

[31] Masuko Memorial Hospital,undefined

[32] Saiseikai Niigata Daini Hospital,undefined

[33] Yokohama City University Graduate School of Medicine,undefined

来源：

Hepatology International | 2020年 / 14卷

关键词：

Glecaprevir; Pibrentasvir; Chronic hepatitis C; Refractory factors; Multicenter study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：225 / 238

页数：13

共 50 条

[1] The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study
Nozaki, Akito
Atsukawa, Masanori
Kondo, Chisa
Toyoda, Hidenori
Chuma, Makoto
Nakamuta, Makoto
Uojima, Haruki
Takaguchi, Koichi
Ikeda, Hiroki
Watanabe, Tsunamasa
Ogawa, Shintaro
Itokawa, Norio
Arai, Taeang
Hiraoka, Atsushi
Asano, Toru
Fujioka, Shinichi
Ikegami, Tadashi
Shima, Toshihide
Ogawa, Chikara
Akahane, Takehiro
Shimada, Noritomo
Fukunishi, Shinya
Abe, Hiroshi
Tsubota, Akihito
Genda, Takuya
Okubo, Hironao
Mikami, Shigeru
Morishita, Asahiro
Moriya, Akio
Tani, Joji
Tachi, Yoshihiko
Hotta, Naoki
Ishikawa, Toru
Okanoue, Takeshi
Tanaka, Yasuhito
Kumada, Takashi
Iwakiri, Katsuhiko
Maeda, Shin
HEPATOLOGY INTERNATIONAL, 2020, 14 (02) : 225 - 238
[2] Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
D'Ambrosio, Roberta
Pasulo, Luisa
Puoti, Massimo
Vinci, Maria
Schiavini, Monica
Lazzaroni, Sergio
Soria, Alessandro
Gatti, Federico
Menzaghi, Barbara
Aghemo, Alessio
Capelli, Francesca
Rumi, Maria Grazia
Morini, Lorenzo
Giorgini, Alessia
Pigozzi, Marie Graciella
Rossini, Angelo
Maggiolo, Franco
Pan, Angelo
Memoli, Massimo
Spinelli, Ombretta
Del Poggio, Paolo
Saladino, Valeria
Spinetti, Angiola
De Bona, Anna
Capretti, Andrea
Uberti-Foppa, Caterina
Bonfanti, Paolo
Terreni, Natalia
Menozzi, Fernanda
Colombo, Alberto Eraldo
Giglio, Omar
Centenaro, Riccardo
Borghi, Marta
Baiguera, Chiara
Picciotto, Viviana
Landonio, Simona
Gori, Andrea
Magnani, Carlo
Noventa, Franco
Paolucci, Stefania
Lampertico, Pietro
Fagiuoli, Stefano
JOURNAL OF HEPATOLOGY, 2019, 70 (03) : 379 - 387
[3] Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C
Hsu, Shih-Jer
Chiu, Min-Chin
Fang, Yu-Jen
Yang, Tsung-Hua
Yu, Jian-Jyun
Chen, Chieh-Chang
Kuo, Chia-Chi
Lee, Ji-Yuh
Chen, Chien-Hung
Chen, Ding-Shinn
Kao, Jia-Horng
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (08) : 1187 - 1192
[4] Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study
Mizuochi, Tatsuki
Iwama, Itaru
Inui, Ayano
Ito, Yoshinori
Takaki, Yugo
Mushiake, Sotaro
Tokuhara, Daisuke
Ishige, Takashi
Ito, Koichi
Murakami, Jun
Hishiki, Haruka
Mikami, Hitoshi
Bessho, Kazuhiko
Kato, Ken
Yasuda, Ryosuke
Yamashita, Yushiro
Tanaka, Yasuhito
Tajiri, Hitoshi
JOURNAL OF GASTROENTEROLOGY, 2023, 58 (04) : 405 - 412
[5] Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study
Tatsuki Mizuochi
Itaru Iwama
Ayano Inui
Yoshinori Ito
Yugo Takaki
Sotaro Mushiake
Daisuke Tokuhara
Takashi Ishige
Koichi Ito
Jun Murakami
Haruka Hishiki
Hitoshi Mikami
Kazuhiko Bessho
Ken Kato
Ryosuke Yasuda
Yushiro Yamashita
Yasuhito Tanaka
Hitoshi Tajiri
Journal of Gastroenterology, 2023, 58 : 405 - 412
[6] Real-World Effectiveness and Safety of Glecaprevir/Pibrentasvir for the Treatment of Chronic Hepatitis C: A Prospective Cohort Study in Portugal
Vera, Jose
Gomes, Andre
Povoas, Diana
Seixas, Diana
Maltez, Fernando
Pedroto, Isabel
Maia, Luis
Mota, Margarida
Vieira, Maria Joao
Manata, Maria Jose
Ferreira, Paula
Lino, Sara
Guedes, Tiago P. E. R. E. I. R. A.
Marques, Nuno
ACTA MEDICA PORTUGUESA, 2024, 37 (05) : 323 - 333
[7] Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
Liu, Chen-Hua
Liu, Chun-Jen
Hung, Chien-Ching
Hsieh, Szu-Min
Su, Tung-Hung
Sun, Hsin-Yun
Tseng, Tai-Chung
Chen, Pei-Jer
Chen, Ding-Shinn
Kao, Jia-Horng
LIVER INTERNATIONAL, 2020, 40 (04) : 758 - 768
[8] Safety and Efficacy of Glecaprevir Plus Pibrentasvir Combination Therapy for Patients with Chronic Hepatitis C Virus in Real World, Multicenter Study
Tamori, Akihiro
Inoue, Kazuaki
Iwasa, Motoh
Nouso, Kazuhiro
Minami, Masahito
Kagawa, Tatehiro
Uchida, Sawako
Enomoto, Masaru
Kawada, Norifumi
HEPATOLOGY, 2018, 68 : 420A - 421A
[9] Effectiveness and Safety of Glecaprevir/Pibrentasvir in Italian Children and Adolescents With Chronic Hepatitis C: A Real-Word, Multicenter Study
Stinco, Mariangela
Rubino, Chiara
Bartolini, Elisa
Nuti, Federica
Paolella, Giulia
Nebbia, Gabriella
Silvestro, Erika
Garazzino, Silvia
Nicastro, Emanuele
D'Antiga, Lorenzo
Zanchi, Chiara
Morra, Laura
Iorio, Raffaele
Di Dato, Fabiola
Maggiore, Giuseppe
Sartorelli, Maria Rita
Comparcola, Donatella
Stracuzzi, Marta
Giacomet, Vania
Musto, Francesca
Pinon, Michele
Calvo, Pierluigi
Carloni, Ines
Zallocco, Federica
Cananzi, Mara
Trapani, Sandra
Indolfi, Giuseppe
LIVER INTERNATIONAL, 2025, 45 (04)
[10] Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland
Mullhaupt, Beat
Semela, David
Ruckstuhl, Lisa
Magenta, Lorenzo
Clerc, Olivier
Torgler, Ralph
Negro, Francesco
Semmo, Nasser
SWISS MEDICAL WEEKLY, 2021, 151

← 1 2 3 4 5 →